Governance Bio-Techne Corporation

TECH

US09073M1045

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-24 pm EST			5-day change	1st Jan Change
77.05 ^USD	+0.18%		+1.61%	+6.97%

Jan. 14	Bio-Techne Corporation Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 10:30 AM
Jan. 10	Bio-Techne Expands R&D Systems Ai-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine	CI

Executive Committee: Bio-Techne Corporation

Manager

Positions heldSince

Kim Kelderman

58 year

Chief Executive Officer	2024-01-31
President	2024-01-31

James Hippel

54 year

Director of Finance/CFO

2014-03-31

David Clair

Investor Relations Contact

2019-09-30

Shane Bohnen

50 year

General Counsel	2023-03-02
Corporate Officer/Principal	2023-03-02
Corporate Secretary	2023-03-02

Composition of the Board of Directors: Bio-Techne Corporation

Director

CommitteesSince

Robert Baumgartner

69 year

Audit Committee	2012-11-01
Compensation Committee	2024-10-23

Joseph Keegan

72 year

Audit Committee Chair	2015-12-31
Governance Committee Chair	2015-12-31
Nominating Committee Chair	2015-12-31
Compensation Committee	2017-10-25
Governance Committee	2024-10-23
Nominating Committee	2024-10-23

Julie Bushman

63 year

Audit Committee	2020-07-30
Compensation Committee	2015-12-31
HR Committee	2015-12-31
Finance Committee	2020-07-07
Compensation Committee Chair

John Higgins

55 year

Governance Committee	2009-05-18
Nominating Committee	2009-05-18
Audit Committee Chair	2013-09-25
Compensation Committee	2022-10-31
HR Committee	2022-10-31

Alpna Seth

62 year

Governance Committee Chair	2024-10-23
Nominating Committee Chair	2024-10-23
Compensation Committee	2023-04-30

Rupert Vessey

60 year

Compensation Committee

2019-06-25

Judith Klimovsky

68 year

Director/Board Member	2024-04-23
Independent Dir/Board Member	2024-04-23

Kim Kelderman

58 year

Director/Board Member

2023-10-31

Roeland Nusse

75 year

Director/Board Member	2010-05-25
Independent Dir/Board Member	2010-05-25

Latest Appointments: Bio-Techne Corporation

Bio-Techne Corporation Appoints Dr. Judith Klimovsky to Board of Directors	24-04-30	CI
Bio-Techne Corporation Appoints Kim Kelderman as Chief Executive Officer Effective February 1, 2024	24-01-05	CI
Bio-Techne Corporation Announces Executive Changes	24-01-05	CI
Bio-Techne Says CEO Chuck Kummeth to Retire, Names Kim Kelderman Successor	23-10-19	MT
Bio-Techne Corporation Announces Executive Changes	23-10-19	CI
Bio-Techne Corporation Announces Chief Executive Officer Changes	23-10-19	CI
Bio-Techne Corporation Announces Executive Changes, Effective March 3, 2023	23-01-31	CI

More news

Former Officers and Directors: Bio-Techne Corporation

Insider

Positions held

SinceUntil

Randolph Steer

Director/Board Member	1989-12-31	2024-10-22
Independent Dir/Board Member	1989-12-31	2024-10-22

Robert Gavin

Corporate Officer/Principal

2014-11-24

2024-06-30

Charles Kummeth

Director/Board Member	2013-03-31	2024-01-31
Chief Executive Officer	2013-03-31	2024-01-31
President	2013-03-31	2024-01-31

Brenda Furlow

Compliance Officer	2014-08-03	2023-03-02
General Counsel	2014-08-03	2023-03-02
Corporate Secretary	2014-08-03	2023-03-02

Brenda Everson

Human Resources Officer

2022-01-09

Struan Robertson

Human Resources Officer

2015-07-31

2022-01-09

Norman Eansor

Corporate Officer/Principal

2015-03-31

2022-01-02

Robert Monroe

Chief Tech/Sci/R&D Officer

2018-03-31

2021-12-31

Ellen Scipta

Corporate Officer/Principal

2014-12-31

2021-01-31

Harold Wiens

Director/Board Member	2014-05-14	2020-10-28
Independent Dir/Board Member	2014-05-14	2020-10-28

Karen Padgett

Sales & Marketing

2013-12-31

2018-12-31

Charles A. Dinarello

Director/Board Member	2005-11-28	2018-10-24
Independent Dir/Board Member	2005-11-28	2018-10-24

J. Fernando Bazan

Chief Tech/Sci/R&D Officer

2013-07-31

2018-04-23

Karen Holbrook

Director/Board Member	2007-02-11	2017-12-30
Independent Dir/Board Member	2007-02-11	2017-12-30

Roger C. Lucas

Director/Board Member	1984-12-31	2016-12-31
Independent Dir/Board Member	1984-12-31	2016-12-31

Jenny Rooke

Consultant / Advisor

2013-12-31

2016-03-01

Howard V. O'Connell

Director/Board Member	1984-12-31	2015-06-29
Independent Dir/Board Member	1984-12-31	2015-06-29

Gregory Melsen

Chief Executive Officer	2012-11-30	2013-02-28
Director of Finance/CFO	2004-11-30	2014-02-02
Treasurer	2004-11-30	2014-02-02

Frank Mortari

Corporate Officer/Principal

2012-12-31

Thomas E. Oland

Chairman	1985-11-30	2012-10-31
President	1985-11-30	2012-11-29
Treasurer	1985-11-30	2012-03-20

Kevin J. Reagan

Corporate Officer/Principal

2011-12-31

G. Arthur Herbert

Director/Board Member

1988-12-31

Monica Tsang

Chief Tech/Sci/R&D Officer

1995-02-28

2007-06-29

Richard A. Krzyzek

Corporate Officer/Principal

2007-04-30

Lowell Sears

Director/Board Member

1993-12-31

2002-12-31

Timothy M. Heaney

Director/Board Member	1999-08-31	2002-08-31
General Counsel	1999-08-31	2002-08-31

Marcel Veronneau

Corporate Officer/Principal

1995-02-28

Mike Hodges

Corporate Officer/Principal

Kathleen M. Backes

Comptroller/Controller/Auditor

Scott Osgood

Corporate Officer/Principal

Kevin Gould

Corporate Officer/Principal

2015-06-30

James A. Weatherbee

Chief Tech/Sci/R&D Officer

Christopher Henney

Director/Board Member

Age distribution of managers

Parity Men Women

Male	13
Female	2

Of which Executive Committee

Male	4
Female	0

Of which Directors

Male	8
Female	1

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools 71.5%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.1%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.4%). Net sales are distributed geographically as follows: the United States (56.7%), the United Kingdom (4.3%), Europe-Middle East-Africa (20.8%), China (8.6%), Asia-Pacific (6.5%) and others (3.1%).

Employees

3,100

Sector

Biotechnology & Medical Research

Calendar

2025-02-05 - Q2 2025 Earnings Release

More about the company